Cannabinoid receptor 2 expression in early-stage non-small cell lung cancers identifies patients with good prognosis and longer survival

BACKGROUND: Non-small cell lung cancer (NSCLC) is a leading cause of cancer-related death with a 5-year survival of only 21%. Reliable prognostic and/or predictive biomarkers are needed to improve NSCLC patient stratification, particularly in curative disease stages. Since the endogenous cannabinoid...

Descripción completa

Detalles Bibliográficos
Autores principales: Vidlarova, Monika, Berta, Emil, Prasil, Petr, Prokopova, Andrea, Gurska, Sona, Khoylou, Marta, Rehulkova, Alona, Kourilova, Pavla, Chudacek, Josef, Szkorupa, Marek, Klein, Jiri, Skarda, Jozef, Srovnal, Josef, Hajduch, Marian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9641041/
https://www.ncbi.nlm.nih.gov/pubmed/36386452
http://dx.doi.org/10.21037/tlcr-22-247

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9641041/
https://www.ncbi.nlm.nih.gov/pubmed/36386452
http://dx.doi.org/10.21037/tlcr-22-247

Ejemplares similares